Lisa Richardson, MD, MPH, director of the Centers for Disease Control and Prevention’s (CDC’s) Division of Cancer Prevention and Control, joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss CDC’s initiatives for cancer prevention and screening during the COVID-19 coronavirus and flu season. The conversation also covers how oncology nurses can help improve declining screening rates and access a new database of cancer incidence and biomarkers. The advertising messages in this episode are sponsored by Coherus BioSciences.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Episode Notes Check out these resources from today’s episode: Oncology Nursing Podcast Episode 96: The COVID-19 Coronavirus and Cancer Care Oncology Nursing Podcast Episode 97: COVID-19 Cancer Care Lessons From Seattle and New York ONS Voice article: How Can ONS Support Members in Today’s Practice Changes? ONS Voice article: COVID-19 Fact Sheet and Implications for Patients With Cancer ONS Voice COVID-19 topic page ONS Information on the Coronavirus (COVID-19) ONS Advocacy During COVID-19 Pandemic ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic Dr. Lisa Richardson’s biography Talk to Someone, virtual simulation with cancer survivor Linda Staying Well While Staying at Home Best Remedy for COVID-19 Is Prevention Cancer, the Flu, and You The National Comprehensive Cancer Network (NCCN) makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Hematopoietic Growth Factors. V.2.2020. © National Comprehensive Cancer Network, Inc., 2020. All rights reserved. Accessed July 10, 2020. To view the most recent and complete version of the guideline, go online to NCCN.org.